All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| (19Z,22Z,25Z,28Z)-tetratriacontatetraenoic acid | CHEBI_77536 | [An omega-6 fatty acid that is tetratriacontanoic acid having four double bonds located at positions 19, 22, 25 and 28 (the 15Z,18Z,21Z,24Z-isomer).] |
| 5-carboxymethylaminomethyl-2'-O-methyluridine 5'-monophosphate(1-) residue | CHEBI_74511 | [An organic anionic group that is the conjugate base of 5-carboxymethylaminomethyl-2'-O-methyluridine 5'-monophosphate residue.] |
| 5-carboxymethylaminomethyl-2'-O-methyluridine 5'-monophosphate residue | CHEBI_74784 | [A nucleotide residue derived from 5-carboxymethylaminomethyl-2'-O-methyluridine 5'-monophosphate.] |
| (17Z,20Z,23Z,26Z)-dotriacontatetraenoyl-CoA | CHEBI_74512 | [An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (17Z,20Z,23Z,26Z)-dotriacontatetraenoic acid.] |
| (17Z,20Z,23Z,26Z)-dotriacontatetraenoyl-CoA(4-) | CHEBI_74289 | [A polyunsaturated fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (17Z,20Z,23Z,26Z)-dotriacontatetraenoyl-CoA.] |
| (17Z,20Z,23Z,26Z)-dotriacontatetraenoic acid | CHEBI_77535 | [A very long-chain omega-6 fatty acid that is tetracosanoic acid having four double bonds located at positions 17, 20, 23 and 26 (the 17Z,20Z,23Z,26Z-isomer).] |
| N(2),N(2)-dimethylguanosine 5'-monophosphate(1-) residue | CHEBI_74513 | [An organic anionic group obtained by deprotonation of the free phosphate OH group of N(2),N(2)-dimethylguanosine 5'-phosphate residue.] |
| N(2),N(2)-dimethylguanosine 5'-monophosphate residue | CHEBI_74786 | [A nucleotide residue derived from N(2),N(2)-dimethylguanosine 5'-monophosphate.] |
| 6-aminonicotinamide | CHEBI_74514 | [A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 6-aminonicotinic acid with ammonia. An inhibitor of the NADP(+)-dependent enzyme, 6-phosphogluconate dehydrogenase, it interferes with glycolysis, resulting in ATP depletion and synergizes with DNA-crosslinking chemotherapy drugs, such as cisplatin, in killing cancer cells.] |
| EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor | CHEBI_74520 | [An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase (EC 1.1.1.44).] |
| 6-aminonicotinic acid | CHEBI_68583 | [An aminonicotinic acid in which the amino group is situated at position 6 of the pyridine ring.] |
| (19Z,22Z,25Z,28Z)-3-oxotetratriacontatetraenoyl-CoA | CHEBI_74515 | [An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (19Z,22Z,25Z,28Z)-3-oxotetratriacontatetraenoic acid.] |
| 3-oxo-fatty acyl-CoA | CHEBI_15489 | [An oxo fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of any 3-oxo-fatty acid..] |
| (19Z,22Z,25Z,28Z)-3-oxotetratriacontatetraenoyl-CoA(4-) | CHEBI_74290 | [A 3-oxo-fatty acyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate functions of (19Z,22Z,25Z,28Z)-3-oxotetratriacontatetraenoyl-CoA.] |
| CHEBI_74516 | CHEBI_74516 | |
| propionyl adenylate | CHEBI_74517 | [A member of the class of adenosines that is adenosine with the hydrogen on the 5'-hydroxy group replaced with a propanoyl group.] |
| pharmacological role | CHEBI_52210 | [A biological role which describes how a drug interacts within a biological system and how the interactions affect its medicinal properties.] |
| EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor | CHEBI_76835 | [An EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor that uses NAD(+) or NADP(+) as acceptor (EC 1.1.1.*).] |
| CHEBI_49543 | CHEBI_49543 | |
| AcNADH | CHEBI_74521 | [A dinucleotide that is NADH with the amide group om the nictotinamide ring replaced with an acetyl group.] |